WONDFO OXAZEPAM URINE TEST (BZO 200) AND WONDFO METHAMPHETAMINE URINE TEST (MET 300)

FDA 510(k) Premarket Notification · Submission K132630 · Applicant: Guangzhou Wondfo Biotech Co., Ltd.

Public Record 510(k) Submission Decision Date: 2013-09-27 510(k) record compiled from public FDA source records.

Submission Details & Decision

Normalized public record details for 510(k) notification K132630.

Source Dataset
FDA 510(k) Premarket Notifications
510(k) Number
K132630
Device Name
WONDFO OXAZEPAM URINE TEST (BZO 200) AND WONDFO METHAMPHETAMINE URINE TEST (MET 300)
Product Code
DJC
Decision Date
2013-09-27
Decision / Status
Substantially Equivalent (SESE)
Advisory Committee
Clinical Toxicology (TX)
Clearance Type
Traditional
Third Party Flag
N
Date Received
2013-08-22

Related Establishments / Registrations

Public Record Disclaimer

This page represents an index of public-record FDA premarket notification filings. AvaSpecs is a private aggregator and is not affiliated with the FDA or any government agency. This page does not constitute medical, safety, legal, regulatory, or compliance advice. Information may be outdated or incomplete. Refer to official government source files for critical decisions.

Account Required Full available specs will require a free AvaSpecs account.